Expression of a recombinant Toxoplasma gondii ROP2 fragment as a fusion protein in bacteria circumvents insolubility and proteolytic degradation

Protein Expression and Purification

Volumn 17, Issue 3, 1999, Pages 392-400

  Jacquet, Alain ^a   Daminet, Véronique ^a   Haumont, Michèle ^a   Garcia, Lida ^a   Chaudoir, Sylvie ^a   Bollen, Alex ^a   Biemans, Ralph ^a  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOXY TERMINAL SEQUENCE; CHROMATOGRAPHY; DETERGENT; ESCHERICHIA COLI; GEL FILTRATION; HYBRID PROTEIN; IMMUNOGENICITY; MALTOSE BINDING PROTEIN; PROTEIN AGGREGATION; PROTEIN CONFORMATION; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN HYDROLYSIS; PROTEIN PURIFICATION; RECOMBINANT PROTEIN; SOLUBILITY; SOLUBILIZATION; THIOREDOXIN; TOXOPLASMA GONDII;

EID: 0033486169     PISSN: 10465928     EISSN: None     Source Type: Journal    
DOI: 10.1006/prep.1999.1150     Document Type: Article

References (22)

1. Israelski D. M., Remington J. S. Toxoplasmosis in the non-AIDS-immunocompromised host. Curr. Clin. Top. Infect. Dis. 13:1993;322-356.
2. Wong S. Y., Remington J. S. Toxoplasmosis in pregnancy. Clin. Infect. Dis. 18:1994;727-729.
3. Luft B. J., Remington J. S. Toxoplasmosis encephalitis in AIDS. Clin. Infect. Dis. 15:1992;211-222.
4. + T lymphocytes in IFN-γ production and protective immunity induced by an attenuated Toxoplasma gondii vaccine. J. Immunol. 146:1991;286-292.
5. Suzuki Y., Orellana M. A., Schreiber R. D., Remington J. S. Interferon-γ: The major mediator of resistance against Toxoplasma gondii. Science. 240:1988;516-518.
6. + T cells and accompanied by overproduction of IL-12, IFNγ and TNF-α J. Immunol. 157:1996;798-805.
7. Beckers C. J. M., Dubremetz J-F., Mercereau-Puijalon O., Joiner K. The Toxoplasma gondii rhoptry protein ROP2 is inserted into the parasitophorous vacuole membrane, surrounding the intracellular parasite, and is exposed to the host cell cytoplasm. J. Cell Biol. 4:1994;947-961.
8. Saavedra R., de Meuter F., Delcourt J.-L., Hérion P. Human T cell clone identifies a potentially protective 54-kDa protein antigen of Toxoplasma gondii cloned and expressed in E. coli. J. Immunol. 147:1991;1975-1982.
9. Saavedra R., Becerill M. A., Dubeaux C., Lippens R., De Vos M-J., Hérion P., Bollen A. Epitopes recognized by human T lymphocytes in the ROP2 protein antigen of Toxoplasma gondii. Infect. Immun. 64:1996;3858-3862.
10. Van Gelder P., Bosman F., De Meuter F., Van Heuverswyn H., Hérion P. Serodiagnosis of toxoplasmosis by using a recombinant form of the 54-kilodalton rhoptry antigen expressed in Escherichia coli. J. Clin. Microbiol. 31:1993;9-15.
11. Martin V., Arcavi M., Santillan G., Amendoeira M. R. R., De Souza Neves E., Griemberg G., Guarnera E., Garberi J. C., Angel S. O. Detection of human Toxoplasma-specific immunoglobulins A, M, and G with a recombinant Toxoplasma gondii Rop2 protein. Clin. Diagn. Lab. Immunol. 5:1998;627-631.
12. Coughlan S. N., Saman S., Jacobs D., Mercier C., Cesbron-Delauw M. F., Trees A. J. Cellular and humoral immune responses to recombinant antigens in sheep infected with Toxoplasma gondii. Parasite Immunol. 17:1995;465-468.
13. Ford C. F., Suominen I., Glatz C. E. Fusion tails for the recovery and purification of recombinant proteins. Protein Expression Purif. 2:1991;95-107.
14. LaVallie E. R., DiBlasio E. A., Kovacic S., Grant K. L., Schendel P. F., McCoy J. M. A thioredoxin gene fusion expression system that circumvents inclusion body formation in the E. coli cytoplasm. BioTechnology. 11:1993;187-193.
15. Riggs P. Introduction to expression by fusion vectors: Expression and purification of maltose-binding protein fusions. Ausubel. Current Protocols in Molecular Biology. 1990;16.4.1-16.4.3 Greene Associates/Wiley Interscience, New York.
16. Murby M., Cedregen L., Nilsson J., Nygren P. A., Hammarberg B., Nilsson B., Enfors S. O., Uhlen M. Stabilization of recombinant proteins from proteolytic degradation in Escherichia coli using a dual affinity fusion strategy. Biotechnol. Appl. Biochem. 14:1991;336-346.
17. Marinez A., Knappskog P. M., Olafsdottir S., Doskeland A. P., Eiken H. G., Svebak R. M., Bozzini M., Apold J., Flatmark T. Expression of recombinant human phenylalanine hydroxylase as fusion protein in Escherichia coli circumvents proteolytic degradation by host cell proteases. Isolation and characterization of the wild-type enzyme. Biochem. J. 306:1995;589-597.
18. Maniatis T., Fritsch E. F., Sambrook J. Molecular Cloning: A Laboratory Manual. 1982;Cold Spring Harbor Laboratory Press, Cold Spring Harbor.
19. Heuterspreute M., Ha Thi V., Emery S., Tournis-Gamble S., Kennedy N., Davison J. Vector with restriction site bank IV. PJRD184, a 3793-bp plasmid vector having 43 unique cloning sites. Gene. 39:1985;299-304.
20. Cockett M. I., Bebbington C. R., Yarranton G. T. High level expression of tissue inhibitor of metalloproteinases in chines hamster ovary cells using glutamine synthetase gene amplification. BioTechnology. 8:1990;662-667.
21. Sachdev D., Chirgwin J. M. Solubility of proteins isolated from inclusion bodies is enhanced by fusion to maltose-binding protein. Protein Expression Purif. 12:1998;122-132.
22. Reddy A., Grimwood B. G., Plummer T. H., Tarentino A. L. High-level expression of the endo-β-N-acetylglucosaminidase F2 gene in E. coli: one step purification to homogeneity. Glycobiology. 8:1998;633-636.